Delpha Capital Management’s Medpace MEDP Stock Holding History

Delpha Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,253	Closed	-$45K	–	773
2017 Q4	$45K	Buy	+1,253	New	+$43.9K	0.05%	353

Other funds holding MEDP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BCA

Bernzott Capital Advisors Camarillo, California $250M AUM 26.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Delpha Capital Management's MEDP Position: Q1 2018 in Review

Delpha Capital Management sold out of Medpace (MEDP) in Q1 2018, closing a stake of 1,253 shares — an estimated $45K sold.

Delpha Capital Management first reported a position in MEDP in Q4 2017 and held it in 1 quarter. The position peaked at $45K in Q4 2017. 113 funds tracked by Wall St. Rank hold MEDP as of Q1 2018.

Delpha Capital Management reported no remaining Medpace position as of Q1 2018 after selling out during the quarter.
Delpha Capital Management sold 1,253 Medpace shares in Q1 2018, an estimated $45K.
Delpha Capital Management first reported a position in Medpace in Q4 2017 and held it in 1 quarter.
Delpha Capital Management's Medpace position peaked at $45K in Q4 2017.
113 funds tracked by Wall St. Rank held Medpace as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.